Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $789.61M | $759.85M | $826.42M | $769.05M | $745.34M | $598.12M | $657.29M | $625.71M |
| Cost of revenue | $241.44M | $234.07M | $261.11M | $252.53M | $248.77M | $195.40M | $263.44M | $270.52M |
| Gross profit | $548.17M | $525.79M | $565.31M | $516.52M | $496.58M | $402.72M | $393.86M | $355.19M |
| Gross margin | 69.4% | 69.2% | 68.4% | 67.2% | 66.6% | 67.3% | 59.9% | 56.8% |
| Research and development | $36.32M | $36.51M | $36.16M | $38.07M | $39.95M | $33.06M | $33.41M | $35.38M |
| Selling, general and administrative | $286.82M | $297.78M | $318.48M | $313.60M | $303.62M | $242.80M | $253.17M | $240.06M |
| Operating expenses | $365.74M | $375.40M | $395.97M | $379.15M | $420.47M | $305.72M | $333.58M | $307.09M |
| Operating income | $182.43M | $150.39M | $169.34M | $137.36M | $76.11M | $97.00M | $60.27M | $48.10M |
| Operating margin | 23.1% | 19.8% | 20.5% | 17.9% | 10.2% | 16.2% | 9.2% | 7.7% |
| EBITDA | $264.97M | $231.83M | $250.32M | $206.13M | $193.44M | $163.71M | $144.96M | $116.62M |
| Interest income | $0 | $0 | $7.14M | — | $0 | $0 | −$4.19M | — |
| Interest expense | $7.07M | $5.43M | −$3.83M | $1.46M | $693.00K | $1.68M | $5.00M | −$775.00K |
| Income before taxes | $189.82M | $157.07M | $169.23M | $143.99M | $188.17M | $103.67M | $24.67M | $57.03M |
| Income taxes | $38.25M | $32.77M | $28.64M | $25.03M | −$14.67M | $28.21M | −$1.84M | $5.20M |
| Net income | $151.57M | $124.30M | $140.59M | $118.97M | $202.85M | $75.46M | $26.51M | $51.84M |
| Net margin | 19.2% | 16.4% | 17.0% | 15.5% | 27.2% | 12.6% | 4.0% | 8.3% |
| EPS, basic | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.19 | $0.38 |
| EPS, diluted | $1.10 | $0.90 | $1.03 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 |
| Diluted shares | 137.38M | 138.19M | 136.56M | 135.39M | 136.50M | 139.77M | 141.05M | 138.06M |
Figures describe Globus Medical shares, not any token. As of Aug 6, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.